Fibrinogen contribution to clot strength in patients with sepsis and hematologic malignancies and thrombocytopenia-a prospective, single-center, analytical, cross-sectional study.

Autor: Crochemore T; Intensive Care Department, Hospital Israelita Albert Einstein, São Paulo, Brazil.; Intensive Care Department, Hospital Moriah, São Paulo, Brazil.; Medical Department, Werfen Latam, São Paulo, Brazil., Scarlatescu E; Intensive Care Department, Bucharest and Fundeni Clinical Institute, University of Medicine and Pharmacy 'Carol Davila,' Bucharest, Romania., Görlinger K; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Essen, Germany.; Medical Department, TEM Innovations/Werfen PBM, Munich, Germany., Rocha MDP; Intensive Care Department, Hospital Moriah, São Paulo, Brazil., Carlos de Campos Guerra J; Laboratory Department, Hospital Israelita Albert Einstein, São Paulo, Brazil.; Departament of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Campêlo DHC; Departament of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil., de Aranda VF; Laboratory Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., Ricardi L; Laboratory Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., Gomes GS; Laboratory Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., Moura RA; Laboratory Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., Assir FF; Research Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., de Sá GRR; Departament of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Lance MD; Department of Anesthesiology, Aga Khan University, Nairobi, Kenya., Hamerschlak N; Departament of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2024 Mar 01; Vol. 8 (2), pp. 102362. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).